Kedrion Biopharma Advances Rare Disease Scientific Evidence Generation at ISTH 2026
New presentations and expert-led scientific discussions underscore Kedrion's commitment to improving diagnosis, supporting disease awareness, and scientific exchange in rare...
Read moreDetails